Aug 14, 2020
IsoPlexis Adds Partnership to Advance COVID-19 Vaccine Development
Mar 12, 2020
IsoPlexis Launches Suite of New Products Enabling Multiple Automated Applications on the IsoLight
Dec 09, 2019
IsoPlexis Announces "Cracking the IsoCode: Single Cell Functional Biomarkers Challenge"
Oct 03, 2019
IsoPlexis' New Software & Applications Pave the Way for Novel Functional Understanding of Single-Cell Immune Activation and Further Application Expansion
Sep 30, 2019
IsoPlexis' Immune Monitoring Contributions in Precision Medicine Highlighted in Comprehensive Publication, "Biomarkers for Immunotherapy of Cancer"
Sep 26, 2019
IsoPlexis Continues Progress on Precision CAR-T cell Characterization with Recent Data Sets & Miltenyi Biotec, Inc. Technology Note
Aug 01, 2019
IsoPlexis Launches First European Office & Initial IsoLight Single Cell Cytokine Detection System at Karolinska Institute in Sweden
Jun 21, 2019
IsoPlexis Receives $4 Million National Cancer Institute Grant for Commercialization of IsoLight for CAR-T Functional Quality Profiling
May 14, 2019
IsoPlexis Completes $25 Million Series C Financing
Aug 20, 2018
IsoPlexis Announces Expansion into Asia Pacific
Jul 24, 2018
IsoPlexis Places IsoLight Single-Cell Proteomic Detection Instrument at Fred Hutchinson Cancer Research Center
Jun 26, 2018
IsoPlexis Announces Research Collaboration with Nektar Therapeutics
Jun 12, 2018
Clinical Data Highlighting Single-Cell Polyfunctionality as a Potential Predictor of Patient Response to CAR-T Cell Therapy Published in "Blood"
May 15, 2018
IsoPlexis Recognized with the Pharma Tech Outlook Cover Story as Top 10 Analytics Solution Provider in 2018
Apr 09, 2018
IsoPlexis' New IsoLight Instrument Receives the Red Dot Design Award for Highest Design Quality
Dec 04, 2017
IsoPlexis To Present New Collaboration Data at the American Society of Hematology Annual Meeting
Dec 04, 2017
IsoPlexis To Present New Collaboration Data at the American Society of Hematology Annual Meeting
Dec 01, 2017
The Scientist Names IsoPlexis Technology The Top Innovation of 2017
Nov 21, 2017
Journal for ImmunoTherapy of Cancer Highlights New Single Cell Bioinformatics Tools From IsoPlexis Used To Characterize Differences in CAR-T Products
Oct 23, 2017
IsoPlexis Receives $1.8M National Cancer Institute Grant To Develop Automated Platform To Assess CAR-T Product Potency and Toxicity and Predict Patient Response